<script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app43.us.archive.org';v.server_ms=116;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include --><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<script type="text/javascript" src="/static/js/timestamp.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/graph-calc.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/auto-complete.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/toolbar.js?v=1531166943.0" charset="utf-8"></script>

<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
.wb-autocomplete-suggestions {
    text-align: left; cursor: default; border: 1px solid #ccc; border-top: 0; background: #fff; box-shadow: -1px 1px 3px rgba(0,0,0,.1);
    position: absolute; display: none; z-index: 2147483647; max-height: 254px; overflow: hidden; overflow-y: auto; box-sizing: border-box;
}
.wb-autocomplete-suggestion { position: relative; padding: 0 .6em; line-height: 23px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; font-size: 1.02em; color: #333; }
.wb-autocomplete-suggestion b { font-weight: bold; }
.wb-autocomplete-suggestion.selected { background: #f0f0f0; }
</style>
<div id="wm-ipp" lang="en" style="display:none;direction:ltr;">
<div style="position:fixed;left:0;top:0;right:0;">
<div id="wm-ipp-inside">
  <div style="position:relative;">
    <div id="wm-logo" style="float:left;width:130px;padding-top:10px;">
      <a href="/web/" title="Wayback Machine home page"><img src="/static/images/toolbar/wayback-toolbar-logo.png" alt="Wayback Machine" width="110" height="39" border="0" /></a>
    </div>
    <div class="r" style="float:right;">
      <div id="wm-btns" style="text-align:right;height:25px;">
                  <div id="wm-save-snapshot-success">success</div>
          <div id="wm-save-snapshot-fail">fail</div>
          <a href="#"
             onclick="__wm.saveSnapshot('https://www.guideline.gov/summaries/downloadcontent/ngc-11192?contentType=xml', '20180712225551')"
             title="Share via My Web Archive"
             id="wm-save-snapshot-open"
          >
            <span class="iconochive-web"></span>
          </a>
          <a href="https://archive.org/account/login.php"
             title="Sign In"
             id="wm-sign-in"
          >
            <span class="iconochive-person"></span>
          </a>
          <span id="wm-save-snapshot-in-progress" class="iconochive-web"></span>
        	<a href="http://faq.web.archive.org/" title="Get some help using the Wayback Machine" style="top:-6px;"><span class="iconochive-question" style="color:rgb(87,186,244);font-size:160%;"></span></a>
	<a id="wm-tb-close" href="#close" onclick="__wm.h(event);return false;" style="top:-2px;" title="Close the toolbar"><span class="iconochive-remove-circle" style="color:#888888;font-size:240%;"></span></a>
      </div>
      <div id="wm-share" style="text-align:right;">
	<a href="#" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=https://web.archive.org/web/20180712225551/https://www.guideline.gov/summaries/downloadcontent/ngc-11192?contentType=xml', '', 'height=400,width=600'); return false;" title="Share on Facebook" style="margin-right:5px;" target="_blank"><span class="iconochive-facebook" style="color:#3b5998;font-size:160%;"></span></a>
	<a href="#" onclick="window.open('https://twitter.com/intent/tweet?text=https://web.archive.org/web/20180712225551/https://www.guideline.gov/summaries/downloadcontent/ngc-11192?contentType=xml&amp;via=internetarchive', '', 'height=400,width=600'); return false;" title="Share on Twitter" style="margin-right:5px;" target="_blank"><span class="iconochive-twitter" style="color:#1dcaff;font-size:160%;"></span></a>
      </div>
    </div>
    <table class="c" style="">
      <tbody>
	<tr>
	  <td class="u" colspan="2">
	    <form target="_top" method="get" action="/web/submit" name="wmtb" id="wmtb"><input type="text" name="url" id="wmtbURL" value="https://www.guideline.gov/summaries/downloadcontent/ngc-11192?contentType=xml" onfocus="this.focus();this.select();" /><input type="hidden" name="type" value="replay" /><input type="hidden" name="date" value="20180712225551" /><input type="submit" value="Go" /></form>
	  </td>
	  <td class="n" rowspan="2" style="width:110px;">
	    <table>
	      <tbody>
		<!-- NEXT/PREV MONTH NAV AND MONTH INDICATOR -->
		<tr class="m">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20180610043236/https://www.guideline.gov/summaries/downloadcontent/ngc-11192?contentType=xml" title="10 Jun 2018"><strong>Jun</strong></a></td>
		  <td class="c" id="displayMonthEl" title="You are here: 22:55:51 Jul 12, 2018">JUL</td>
		  <td class="f" nowrap="nowrap">Aug</td>
		</tr>
		<!-- NEXT/PREV CAPTURE NAV AND DAY OF MONTH INDICATOR -->
		<tr class="d">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20180610043236/https://www.guideline.gov/summaries/downloadcontent/ngc-11192?contentType=xml" title="04:32:36 Jun 10, 2018"><img src="/static/images/toolbar/wm_tb_prv_on.png" alt="Previous capture" width="14" height="16" border="0" /></a></td>
		  <td class="c" id="displayDayEl" style="width:34px;font-size:24px;white-space:nowrap;" title="You are here: 22:55:51 Jul 12, 2018">12</td>
		  <td class="f" nowrap="nowrap"><img src="/static/images/toolbar/wm_tb_nxt_off.png" alt="Next capture" width="14" height="16" border="0" /></td>
		</tr>
		<!-- NEXT/PREV YEAR NAV AND YEAR INDICATOR -->
		<tr class="y">
		  <td class="b" nowrap="nowrap">2017</td>
		  <td class="c" id="displayYearEl" title="You are here: 22:55:51 Jul 12, 2018">2018</td>
		  <td class="f" nowrap="nowrap">2019</td>
		</tr>
	      </tbody>
	    </table>
	  </td>
	</tr>
	<tr>
	  <td class="s">
	    	    <div id="wm-nav-captures">
	      	      <a class="t" href="/web/20180712225551*/https://www.guideline.gov/summaries/downloadcontent/ngc-11192?contentType=xml" title="See a list of every capture for this URL">5 captures</a>
	      <div class="r" title="Timespan for captures of this URL">02 Oct 2017 - 12 Jul 2018</div>
	      </div>
	  </td>
	  <td class="k">
	    <a href="" id="wm-graph-anchor">
	      <div id="wm-ipp-sparkline" title="Explore captures for this URL" style="position: relative">
		<canvas id="wm-sparkline-canvas" width="575" height="27" border="0"></canvas>
	      </div>
	    </a>
	  </td>
	</tr>
      </tbody>
    </table>
    <div style="position:absolute;bottom:0;right:2px;text-align:right;">
      <a id="wm-expand" class="wm-btn wm-closed" href="#expand" onclick="__wm.ex(event);return false;"><span id="wm-expand-icon" class="iconochive-down-solid"></span> <span style="font-size:80%">About this capture</span></a>
    </div>
  </div>
    <div id="wm-capinfo" style="border-top:1px solid #777;display:none; overflow: hidden">
            <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center">COLLECTED BY</div>
    <div style="padding:3px;position:relative" id="wm-collected-by-content">
            <div style="display:inline-block;vertical-align:top;width:50%;">
			<span class="c-logo" style="background-image:url(https://archive.org/services/img/archiveteam);"></span>
		Organization: <a style="color:#33f;" href="https://archive.org/details/archiveteam" target="_new"><span class="wm-title">Archive Team</span></a>
		<div style="max-height:75px;overflow:hidden;position:relative;">
	  <div style="position:absolute;top:0;left:0;width:100%;height:75px;background:linear-gradient(to bottom,rgba(255,255,255,0) 0%,rgba(255,255,255,0) 90%,rgba(255,255,255,255) 100%);"></div>
	  <img align=right src="http://archiveteam.org/images/e/e6/Archiveteam.jpg" width=200> Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed of volunteers and interested parties, and has expanded into a large amount of related projects for saving online and digital history.
<p>
History is littered with hundreds of conflicts over the future of a community, group, location or business that were "resolved" when one of the parties stepped ahead and destroyed what was there. With the original point of contention destroyed, the debates would fall to the wayside. Archive Team believes that by duplicated condemned data, the conversation and debate can continue, as well as the richness and insight gained by keeping the materials. Our projects have ranged in size from a single volunteer downloading the data to a small-but-critical site, to over 100 volunteers stepping forward to acquire terabytes of user-created data to save for future generations.
<p>
The main site for Archive Team is at <a href="http://www.archiveteam.org">archiveteam.org</a> and contains up to the date information on various projects, manifestos, plans and walkthroughs.
<p>
This collection contains the output of many Archive Team projects, both ongoing and completed. Thanks to the generous providing of disk space by the Internet Archive, multi-terabyte datasets can be made available, as well as in use by the <a href="http://archive.org/web/web.php">Wayback Machine</a>, providing a path back to lost websites and work. 
<p>
Our collection has grown to the point of having sub-collections for the type of data we acquire. If you are seeking to browse the contents of these collections, the Wayback Machine is the best first stop. Otherwise, you are free to dig into the stacks to see what you may find.
<p>
<b>The Archive Team Panic Downloads</b> are full pulldowns of currently extant websites, meant to serve as emergency backups for needed sites that are in danger of closing, or which will be missed dearly if suddenly lost due to hard drive crashes or server failures. 
<p>
	</div>
	      </div>
      <div style="display:inline-block;vertical-align:top;width:49%;">
			<span class="c-logo" style="background-image:url(https://archive.org/services/img/archivebot)"></span>
		<div>Collection: <a style="color:#33f;" href="https://archive.org/details/archivebot" target="_new"><span class="wm-title">ArchiveBot: The Archive Team Crowdsourced Crawler</span></a></div>
		<div style="max-height:75px;overflow:hidden;position:relative;">
	  <div style="position:absolute;top:0;left:0;width:100%;height:75px;background:linear-gradient(to bottom,rgba(255,255,255,0) 0%,rgba(255,255,255,0) 90%,rgba(255,255,255,255) 100%);"></div>
	  ArchiveBot is an IRC bot designed to automate the archival of smaller websites (e.g. up to a few hundred thousand URLs). You give it a URL to start at, and it grabs all content under that URL, records it in a WARC, and then uploads that WARC to ArchiveTeam servers for eventual injection into the Internet Archive (or other archive sites).
<p>
To use ArchiveBot, drop by #archivebot on EFNet. To interact with ArchiveBot, you issue commands by typing it into the channel. Note you will need channel operator permissions in order to issue archiving jobs. The dashboard shows the sites being downloaded currently.
<p>
There is a dashboard running for the archivebot process at <a href="http://www.archivebot.com">http://www.archivebot.com</a>.
<p>
ArchiveBot's source code can be found at <a href="https://github.com/ArchiveTeam/ArchiveBot">https://github.com/ArchiveTeam/ArchiveBot</a>.
	</div>
	      </div>
    </div>
    <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center" title="Timestamps for the elements of this page">TIMESTAMPS</div>
    <div>
      <div id="wm-capresources" style="margin:0 5px 5px 5px;max-height:250px;overflow-y:scroll !important"></div>
      <div id="wm-capresources-loading" style="text-align:left;margin:0 20px 5px 5px;display:none"><img src="/static/images/loading.gif" alt="loading" /></div>
    </div>
  </div></div></div></div><script type="text/javascript">
__wm.bt(575,27,25,2,"web","https://www.guideline.gov/summaries/downloadcontent/ngc-11192?contentType=xml","2018-07-12",1996);
</script>
<!-- END WAYBACK TOOLBAR INSERT --><version>
  <xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource>
  <section secid="390" ordby="100" name="General">
    <field fieldid="161" ordby="105" id="391" name="Guideline Title" type="text">
      <fieldvalue value="<div class=&quot;content_title&quot;>Cough in the athlete: CHEST guideline and Expert Panel report.</div>"/>
    </field>
    <field fieldid="97" ordby="110" id="392" name="Bibliographic Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>Boulet LP, Turmel J, Irwin RS, CHEST Expert Cough Panel. Cough in the athlete: CHEST guideline and Expert Panel report. Chest. 2017 Feb;151(2):441-54. [76 references] <a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=27865877&quot; target=&quot;_blank&quot;>PubMed</a></td></tr></table>"/>
    </field>
    <field fieldid="120" ordby="115" id="393" name="Guideline Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the guideline.</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div>"/>
    </field>
  </section>
  <section secid="705" ordby="150" name="NEATS Assessment">
    <field fieldid="183" ordby="10" id="706" name="Disclosure of Guideline Funding Source" type="picklist-one">
      <fieldvalue value="Yes"/>
    </field>
    <field fieldid="184" ordby="20" id="707" name="Disclosure and Management of Financial Conflict of Interests" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="185" ordby="30" id="708" name="Guideline Development Group Composition: Multidisciplinary Group" type="picklist-one">
      <fieldvalue value="Yes"/>
    </field>
    <field fieldid="186" ordby="40" id="709" name="Guideline Development Group Composition: Methodologist Involvement" type="picklist-one">
      <fieldvalue value="Unknown"/>
    </field>
    <field fieldid="187" ordby="50" id="710" name="Guideline Development Group Composition: Patient and Public Perspectives" type="picklist-one">
      <fieldvalue value="1"/>
    </field>
    <field fieldid="188" ordby="60" id="711" name="Use of a Systematic Review of Evidence: Search Strategy" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="189" ordby="70" id="712" name="Use of a Systematic Review of Evidence: Study Selection" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="190" ordby="80" id="713" name="Use of a Systematic Review of Evidence: Synthesis of Evidence" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="191" ordby="90" id="714" name="Evidence Foundations for and Rating Strength of Recommendations: Grading the Quality or Strength of Evidence" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="192" ordby="100" id="715" name="Evidence Foundations for and Rating Strength of Recommendations: Benefits and Harms of Recommendations" type="picklist-one">
      <fieldvalue value="3"/>
    </field>
    <field fieldid="193" ordby="110" id="716" name="Evidence Foundations for and Rating Strength of Recommendations: Evidence Summary Supporting Recommendations" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="194" ordby="120" id="717" name="Evidence Foundations for and Rating Strength of Recommendations: Rating the Strength of Recommendations" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="195" ordby="130" id="718" name="Specific and Unambiguous Articulation of Recommendations" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="196" ordby="140" id="719" name="External Review" type="picklist-one">
      <fieldvalue value="1"/>
    </field>
    <field fieldid="197" ordby="150" id="720" name="Updating" type="picklist-one">
      <fieldvalue value="1"/>
    </field>
  </section>
  <section secid="420" ordby="300" name="Recommendations">
    <field fieldid="151" ordby="310" id="421" name="Major Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The grades of recommendation (<strong>1A&amp;ndash;2C, consensus-based [CB]</strong>) and the approach to rating the quality of evidence are defined at the end of the &quot;Major Recommendations&quot; field.</p>
<ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;>
    <li>In adult and adolescent athletes (&amp;ge;12 years of age) complaining of acute or recurrent cough, the Expert Panel suggests to initially evaluate for the most commonly reported causes of cough in this group such as asthma, exercise induced bronchoconstriction (EIB), respiratory tract infections (RTIs), upper airway cough syndrome (UACS) due to rhinosinus conditions, and environmental exposures related to the sport training environments (<strong>Ungraded, Consensus Based</strong>). </li>
    <li>In adult and adolescent athletes (&amp;ge;12 years of age) complaining of acute or recurrent cough, the Expert Panel suggests that pulmonary function tests, particularly bronchoprovocation challenges, and assessment of allergy to common airborne allergens be performed in the investigation of cough to identify common etiologies such as asthma and EIB, and to evaluate the effects of environmental exposures such as allergens, respiratory irritants, and pollutants (<strong>Grade 2B</strong>). </li>
    <li>In adult and adolescent athletes (&amp;ge;12 years of age) complaining of acute or recurrent cough, the Expert Panel suggests to proceed with a systematic investigation based on suspected cause(s) from initial clinical assessment, with specific attention to the athlete's particular sport and training environment and context (exercise related or not) in which cough occurs, to determine its etiology (<strong>Ungraded, Consensus Based</strong>). </li>
    <li>In adult and adolescent athletes (&amp;ge;12 years of age) complaining of cough, the Expert Panel suggests a treatment trial directed at the suspected causes of cough similarly to the general population, but taking into account the sport performed and training environment. The anti-doping regulations and potential side effects of medications that could interfere with training performances should be reviewed and considered when appropriate (<strong>Ungraded, Consensus Based</strong>).
    <p>Remarks: Anti-doping regulations are provided by the World Anti-Doping Agency (WADA) (<a href=&quot;https://www.wada-ama.org&quot; title=&quot;World Anti-Doping Agency Web site&quot;>https://www.wada-ama.org</a>). The World Anti-Doping Code is a document that brings consistency to anti-doping rules, regulations, and policies worldwide. It is updated annually and the Prohibited List identifies the substances and methods prohibited to athletes in and out of competition. The Global Drug Reference Online (Global DRO) provides athletes and support personnel with information about the prohibited status of specific substances based on the current WADA Prohibited List. The Global DRO provides specific information on products sold in the United Kingdom, Canada, and the United States. The Global DRO is created through a partnership between UK Sport, the Canadian Centre for Ethics in Sport, and the US Anti-Doping Agency (<a href=&quot;http://www.globaldro.com/Home&quot; title=&quot;Global DRO Web site&quot;>http://www.globaldro.com/Home</a>). </p>
    </li>
    <li>In adult and adolescent athletes (&amp;ge;12 years of age) complaining of acute and recurrent cough, the Expert Panel suggests that investigators perform randomized control trials to assess the effects of disease-specific and/or environment-specific (e.g., cold-air-induced cough) treatments on cough because there are minimal data on how to optimally treat cough in these groups (<strong>Ungraded, Consensus Based</strong>). </li>
</ol>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Definitions</span></strong></p>
<p><strong>American College of Chest Physicians (CHEST) Grading System</strong></p>
<table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: American College of Chest Physicians (CHEST) Grading System&quot;>
    <thead>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Grade of Recommendation</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Balance of Benefit vs. Risk and Burdens (Strength of the Recommendation: Level 1 or 2)</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Methodologic Strength of Supporting Evidence (Quality of Body of Evidence: A, B, C, or CB)</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Implications</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;4&quot; scope=&quot;row&quot;>Graded evidence-based guideline recommendations</th>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Strong recommendation, high-quality evidence (1A)</td>
            <td valign=&quot;top&quot;>Benefits clearly outweigh risk and burdens or vice versa</td>
            <td valign=&quot;top&quot;>Consistent evidence from randomized controlled trials (RCTs) without important limitations or exceptionally strong evidence from observational studies</td>
            <td valign=&quot;top&quot;>Recommendation can apply to most patients in most circumstances. Further research is very unlikely to change confidence in the estimate of effect.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Strong recommendation, moderate-quality evidence (1B)</td>
            <td valign=&quot;top&quot;>Benefits clearly outweigh risk and burdens or vice versa</td>
            <td valign=&quot;top&quot;>Evidence from RCTs with important limitations (inconsistent results, methodologic flaws, indirect or imprecise), or very strong evidence from observational studies</td>
            <td valign=&quot;top&quot;>Recommendation can apply to most patients in most circumstances. Higher-quality research may well have an important impact on confidence in the estimate of effect and may change the estimate.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Strong recommendation, low- or very-low-quality evidence (1C)</td>
            <td valign=&quot;top&quot;>Benefits clearly outweigh risk and burdens or vice versa</td>
            <td valign=&quot;top&quot;>Evidence for at least one critical outcome from observational studies, case series, or from RCTs with serious flaws or indirect evidence</td>
            <td valign=&quot;top&quot;>Recommendation can apply to most patients in many circumstances. Higher-quality research is likely to have an important impact on confidence in the estimate of effect and may well change the estimate.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Weak recommendation, high-quality evidence (2A)</td>
            <td valign=&quot;top&quot;>Benefits closely balanced with risks and burden</td>
            <td valign=&quot;top&quot;>Consistent evidence from RCTs without important limitations or exceptionally strong evidence from observational studies</td>
            <td valign=&quot;top&quot;>The best action may differ depending on circumstances or patient's or societal values. Further research is very unlikely to change confidence in the estimate of effect.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Weak recommendation, moderate-quality evidence (2B)</td>
            <td valign=&quot;top&quot;>Benefits closely balanced with risks and burden</td>
            <td valign=&quot;top&quot;>Evidence from RCTs with important limitations (inconsistent results, methodologic flaws, indirect or imprecise) or very strong evidence from observational studies</td>
            <td valign=&quot;top&quot;>Best action may differ depending on circumstances or patient's or societal values. Higher-quality research may well have an important impact on confidence in the estimate of effect and may change the estimate.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Weak recommendation, low- or very-low-quality evidence (2C)</td>
            <td valign=&quot;top&quot;>Uncertainty in the estimates of benefits, risks, and burden; benefits, risk, and burden may be closely balanced</td>
            <td valign=&quot;top&quot;>Evidence for at least one critical outcome from observational studies, case series, or RCTs, with serious flaws or indirect evidence </td>
            <td valign=&quot;top&quot;>Other alternatives may be equally reasonable. Higher-quality research is likely to have an important impact on confidence in the estimate of effect and may well change the estimate.</td>
        </tr>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;4&quot; scope=&quot;row&quot;>Nongraded consensus-based suggestions</th>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Consensus-based (CB)</td>
            <td valign=&quot;top&quot;>Uncertainty due to lack of evidence but expert opinion that benefits outweigh risk and burdens or vice versa</td>
            <td valign=&quot;top&quot;>Insufficient evidence for a graded recommendation</td>
            <td valign=&quot;top&quot;>Future research may well have an important impact on confidence in the estimate of effect and may change the estimate.</td>
        </tr>
    </tbody>
</table></div>"/>
    </field>
    <field fieldid="138" ordby="330" id="423" name="Clinical Algorithm(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>None provided</p></div>"/>
    </field>
  </section>
  <section secid="396" ordby="400" name="Scope">
    <field fieldid="140" ordby="405" id="397" name="Disease/Condition(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Acute or recurrent cough</p></div>"/>
    </field>
    <field fieldid="103" ordby="410" id="398" name="Guideline Category" type="picklist-many">
      <fieldvalue value="Diagnosis"/>
      <fieldvalue value="Evaluation"/>
      <fieldvalue value="Treatment"/>
    </field>
    <field fieldid="113" ordby="415" id="399" name="Clinical Specialty" type="picklist-many">
      <fieldvalue value="Allergy and Immunology"/>
      <fieldvalue value="Family Practice"/>
      <fieldvalue value="Internal Medicine"/>
      <fieldvalue value="Pediatrics"/>
      <fieldvalue value="Pulmonary Medicine"/>
      <fieldvalue value="Sports Medicine"/>
    </field>
    <field fieldid="114" ordby="420" id="400" name="Intended Users" type="picklist-many">
      <fieldvalue value="Advanced Practice Nurses"/>
      <fieldvalue value="Nurses"/>
      <fieldvalue value="Physician Assistants"/>
      <fieldvalue value="Physicians"/>
    </field>
    <field fieldid="129" ordby="425" id="401" name="Guideline Objective(s)" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>To assess the following in the target population: (1) the main causes of acute and recurrent cough, either exercise-induced or not, (2) how cough is assessed, and (3) how cough is treated in this population </li>
    <li>To make specific recommendations or suggestions about identification of the cause of cough as well as the assessment and treatment of cough in the target population </li>
</ul>"/>
    </field>
    <field fieldid="132" ordby="430" id="402" name="Target Population" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Adult and adolescent athletes (aged &amp;ge;12 years) who complain of acute or recurrent cough, regardless of the duration and relationship to exercise</p></div>"/>
    </field>
    <field fieldid="133" ordby="435" id="403" name="Interventions and Practices Considered" type="text">
      <fieldvalue value="<ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;>
    <li>Evaluation for the most commonly reported causes of cough in this group (asthma, exercise-induced bronchoconstriction, respiratory tract infections, upper airway cough syndrome due to rhinosinus conditions, and environmental exposures related to the sport training environment) </li>
    <li>Pulmonary function tests (bronchoprovocation challenge) </li>
    <li>Assessment of allergy to common airborne allergens </li>
    <li>Treatment trial directed at the suspected causes of cough, while being mindful of anti-doping regulations and potential side effects of medications </li>
</ol>"/>
    </field>
    <field fieldid="134" ordby="440" id="404" name="Major Outcomes Considered" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>Diagnostic accuracy (e.g., sensitivity, specificity, positive predictive value, negative predictive value, validity, reliability, responsiveness, feasibility) </li>
    <li>Therapeutic efficacy (e.g., change in clinical practice, impact on patient or provider decision-making) </li>
    <li>Patient outcome efficacy (e.g., acceptability, quality of life, chest pain, depression, or anxiety) </li>
</ul>"/>
    </field>
  </section>
  <section secid="405" ordby="500" name="Methodology">
    <field fieldid="109" ordby="505" id="406" name="Methods Used to Collect/Select the Evidence" type="picklist-many">
      <fieldvalue value="Hand-searches of Published Literature (Primary Sources)"/>
      <fieldvalue value="Hand-searches of Published Literature (Secondary Sources)"/>
      <fieldvalue value="Searches of Electronic Databases"/>
    </field>
    <field fieldid="135" ordby="510" id="407" name="Description of Methods Used to Collect/Select the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Search Strategy</span></strong></p>
<p>Systematic review of the literature was performed. Studies published in PubMed, Scopus, and the Cochrane Library were identified using the following search terms: (cough OR exercise induced asthma OR rhinitis OR sinusitis OR laryngitis OR GERD OR gastro-esophageal reflux OR gastroesophageal reflux OR &quot;chronic eosinophilic bronchitis&quot; OR bronchoconstriction OR &quot;environmental exposures&quot; OR &quot;vocal cord&quot; OR &quot;upper airway diseases&quot; OR allergies) AND (athlete OR athletes OR skiers OR skiing OR swimmers OR swimming OR runners OR rowing OR marathon OR Olympic OR &quot;competitive sports&quot;) were identified. The search was limited to articles in French and English; it began with the initiation of these databases and ended in April 2015.</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Study Selection</span></strong></p>
<p>Being aware that there were only a few clinical trials on cough in the athlete, the Expert Panel included all types of study designs in the list of articles to review. References of included studies were searched to identify additional relevant publications. The study characteristics and inclusion/exclusion criteria were selected from the patient problem or population, intervention, comparison, and outcome (PICO) elements for all key clinical questions (see Table 1 in the original guideline document). To be included, studies had to meet the following criteria: subjects were described as athletes, adults and adolescents aged &amp;ge;12 years who complained of acute or recurrent cough, regardless of the duration and relationship to exercise. A subject was considered an athlete if he/she participated in an organized team or individual sport and took part in regular sport competitions against other athletes. Ideally, the sport had to require some form of systematic and usually intense training, regardless of the level of competition or number of training hours.</p>
<p>Two authors independently analyzed the titles and content of the abstracts recovered to assess inclusion criteria. From the selected titles and abstracts, full reports about potentially relevant studies were obtained, and the authors independently assessed eligibility of the studies. Disagreements were discussed and resolved by consensus. A third author was available to help resolve disagreements if necessary.</p></div>"/>
    </field>
    <field fieldid="136" ordby="515" id="408" name="Number of Source Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Of 1,283 references identified by the search string and screened, 60 articles were included in the analysis. The process of study selection is outlined in Figure 1 (Preferred Reporting Items for Systematic Reviews flow diagram for the study selection) in the original guideline document.</p></div>"/>
    </field>
    <field fieldid="115" ordby="520" id="409" name="Methods Used to Assess the Quality and Strength of the Evidence" type="picklist-choice">
      <fieldvalue value="Weighting According to a Rating Scheme (Scheme Given)"/>
    </field>
    <field fieldid="149" ordby="525" id="410" name="Rating Scheme for the Strength of the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The quality of evidence was based on risk of bias, inconsistency, indirectness, reporting bias, and imprecision. The quality of evidence (i.e., the confidence in estimates) was rated as high (A), moderate (B), and low or very low (C) (see the &quot;Rating Scheme for the Strength of the Recommendations&quot; field).</p></div>"/>
    </field>
    <field fieldid="116" ordby="530" id="411" name="Methods Used to Analyze the Evidence" type="picklist-many">
      <fieldvalue value="Meta-Analysis"/>
      <fieldvalue value="Systematic Review with Evidence Tables"/>
    </field>
    <field fieldid="150" ordby="535" id="412" name="Description of the Methods Used to Analyze the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Data Extraction and Quality Assessment</span></strong></p>
<p>For randomized controlled trials, the reviewers independently assessed the risk of bias criteria using criteria in the Cochrane Reviews. The criteria used were random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias) to the study protocol, blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), and selective reporting (reporting bias). Quality assessment of observational studies was also performed.</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Guideline Framework</span></strong></p>
<p>Grading of recommendations/suggestions was made according to the Grading of Recommendations Assessment, Development and Evaluation framework as adopted by CHEST. This framework separates the process of rating the quality of evidence from that of determining the strength of the recommendation.</p></div>"/>
    </field>
    <field fieldid="112" ordby="540" id="413" name="Methods Used to Formulate the Recommendations" type="picklist-choice">
      <fieldvalue value="Expert Consensus (Delphi)"/>
    </field>
    <field fieldid="145" ordby="545" id="414" name="Description of Methods Used to Formulate the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Guideline Framework</span></strong></p>
<p>Grading of recommendations/suggestions was made according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework as adopted by CHEST. This framework separates the process of rating the quality of evidence from that of determining the strength of the recommendation. The quality of evidence was based on risk of bias, inconsistency, indirectness, reporting bias, and imprecision. The quality of evidence (i.e., the confidence in estimates) was rated as high (A), moderate (B), and low or very low (C). The strength of recommendation was determined based on the quality of evidence and the balance of benefits and harms, patients' values and preferences, and availability of resources. Level 1 represented strong recommendations in which benefits or harms clearly outweighed the other. Level 2 represented a weak recommendation in which it was not clear that the benefits outweighed the harms (or vice versa), and new research could change the direction or strength of these recommendations (see the &quot;Rating Scheme for the Strength of the Recommendations&quot; field).</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Developing Recommendations/Suggestions</span></strong></p>
<p>To be included in this guideline, a recommendation or suggestion had to be voted on by 75% of the eligible members of the entire Cough Expert Panel and achieve ratings of &quot;strongly agree&quot; or &quot;agree&quot; by 80% of the voting panelists. No cough panel member was excluded from voting.</p></div>"/>
    </field>
    <field fieldid="146" ordby="550" id="415" name="Rating Scheme for the Strength of the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>American College of Chest Physicians (CHEST) Grading System</span></strong></p>
<table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: American College of Chest Physicians (CHEST) Grading System&quot;>
    <thead>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Grade of Recommendation</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Balance of Benefit vs. Risk and Burdens (Strength of the Recommendation: Level 1 or 2)</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Methodologic Strength of Supporting Evidence (Quality of Body of Evidence: A, B, C, or CB)</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Implications</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;4&quot; scope=&quot;row&quot;>Graded evidence-based guideline recommendations</th>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Strong recommendation, high-quality evidence (1A)</td>
            <td valign=&quot;top&quot;>Benefits clearly outweigh risk and burdens or vice versa</td>
            <td valign=&quot;top&quot;>Consistent evidence from randomized controlled trials (RCTs) without important limitations or exceptionally strong evidence from observational studies</td>
            <td valign=&quot;top&quot;>Recommendation can apply to most patients in most circumstances. Further research is very unlikely to change confidence in the estimate of effect.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Strong recommendation, moderate-quality evidence (1B)</td>
            <td valign=&quot;top&quot;>Benefits clearly outweigh risk and burdens or vice versa</td>
            <td valign=&quot;top&quot;>Evidence from RCTs with important limitations (inconsistent results, methodologic flaws, indirect or imprecise), or very strong evidence from observational studies</td>
            <td valign=&quot;top&quot;>Recommendation can apply to most patients in most circumstances. Higher-quality research may well have an important impact on confidence in the estimate of effect and may change the estimate.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Strong recommendation, low- or very-low-quality evidence (1C)</td>
            <td valign=&quot;top&quot;>Benefits clearly outweigh risk and burdens or vice versa</td>
            <td valign=&quot;top&quot;>Evidence for at least one critical outcome from observational studies, case series, or from RCTs with serious flaws or indirect evidence</td>
            <td valign=&quot;top&quot;>Recommendation can apply to most patients in many circumstances. Higher-quality research is likely to have an important impact on confidence in the estimate of effect and may well change the estimate.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Weak recommendation, high-quality evidence (2A)</td>
            <td valign=&quot;top&quot;>Benefits closely balanced with risks and burden</td>
            <td valign=&quot;top&quot;>Consistent evidence from RCTs without important limitations or exceptionally strong evidence from observational studies</td>
            <td valign=&quot;top&quot;>The best action may differ depending on circumstances or patient's or societal values. Further research is very unlikely to change confidence in the estimate of effect.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Weak recommendation, moderate-quality evidence (2B)</td>
            <td valign=&quot;top&quot;>Benefits closely balanced with risks and burden</td>
            <td valign=&quot;top&quot;>Evidence from RCTs with important limitations (inconsistent results, methodologic flaws, indirect or imprecise) or very strong evidence from observational studies</td>
            <td valign=&quot;top&quot;>Best action may differ depending on circumstances or patient's or societal values. Higher-quality research may well have an important impact on confidence in the estimate of effect and may change the estimate.</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Weak recommendation, low- or very-low-quality evidence (2C)</td>
            <td valign=&quot;top&quot;>Uncertainty in the estimates of benefits, risks, and burden; benefits, risk, and burden may be closely balanced</td>
            <td valign=&quot;top&quot;>Evidence for at least one critical outcome from observational studies, case series, or RCTs, with serious flaws or indirect evidence </td>
            <td valign=&quot;top&quot;>Other alternatives may be equally reasonable. Higher-quality research is likely to have an important impact on confidence in the estimate of effect and may well change the estimate.</td>
        </tr>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;4&quot; scope=&quot;row&quot;>Nongraded consensus-based suggestions</th>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Consensus-based (CB)</td>
            <td valign=&quot;top&quot;>Uncertainty due to lack of evidence but expert opinion that benefits outweigh risk and burdens or vice versa</td>
            <td valign=&quot;top&quot;>Insufficient evidence for a graded recommendation</td>
            <td valign=&quot;top&quot;>Future research may well have an important impact on confidence in the estimate of effect and may change the estimate.</td>
        </tr>
    </tbody>
</table></div>"/>
    </field>
    <field fieldid="148" ordby="565" id="417" name="Cost Analysis" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div>"/>
    </field>
    <field fieldid="104" ordby="570" id="418" name="Method of Guideline Validation" type="picklist-choice">
      <fieldvalue value="Not stated"/>
    </field>
    <field fieldid="130" ordby="575" id="419" name="Description of Method of Guideline Validation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Not applicable</p></div>"/>
    </field>
  </section>
  <section secid="424" ordby="600" name="Evidence Supporting the Recommendations">
    <field fieldid="139" ordby="610" id="426" name="Type of Evidence Supporting the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The type of supporting evidence is identified and graded for each recommendation (see the &quot;Major Recommendations&quot; field).</p></div>"/>
    </field>
  </section>
  <section secid="427" ordby="700" name="Benefits/Harms of Implementing the Guideline Recommendations">
    <field fieldid="152" ordby="705" id="428" name="Potential Benefits" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The guideline aimed to provide specific recommendations or suggestions about identification of the cause of cough as well as the assessment and treatment of cough in this population. It was suggested that evaluation and management of cough in athletes should take into account many specific characteristics and special considerations for athletes, such as daily training, training environment, doping regulations, and frequent traveling. As each cause of cough might have a specific treatment, accurate diagnosis is essential to avoid using unnecessary medication.</p></div>"/>
    </field>
    <field fieldid="153" ordby="710" id="429" name="Potential Harms" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Medication side effects</p></div>"/>
    </field>
  </section>
  <section secid="432" ordby="900" name="Qualifying Statements">
    <field fieldid="137" ordby="905" id="433" name="Qualifying Statements" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Disclaimer</span></strong></p>
<p>American College of Chest Physician (CHEST) guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and physician advice, which always should be sought for any medical condition. The complete disclaimer for this guideline can be accessed at <a href=&quot;http://www.chestnet.org/Guidelines-and-Resources&quot; title=&quot;CHEST Web site&quot;>http://www.chestnet.org/Guidelines-and-Resources</a>. </p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Strengths and Limitations</span></strong></p>
<p>Even though cough is a very commonly reported respiratory symptom in athletes, analysis of the literature stresses the paucity of data on cough in the athlete. The strengths of this analysis include the extensive review of &amp;gt; 1,200 publications obtained according to the key words selected, the methodology used to perform the analysis, and its review by the CHEST Expert Cough Panel.</p>
<p>Its limitations are associated with the lack of high quality studies, the variable definition of an athlete among reports (resulting in a relatively heterogeneous group of athletes), the lack of specific analysis of cough among other types of respiratory symptoms, and the variable outcomes chosen to assess cough response to treatment. In addition, the number of patients enrolled in the studies was small.</p></div>"/>
    </field>
  </section>
  <section secid="434" ordby="1000" name="Implementation of the Guideline">
    <field fieldid="131" ordby="1010" id="436" name="Description of Implementation Strategy" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>An implementation strategy was not provided.</p></div>"/>
    </field>
    <field fieldid="117" ordby="1015" id="437" name="Implementation Tools" type="picklist-many">
      <fieldvalue value="Mobile Device Resources"/>
    </field>
  </section>
  <section secid="439" ordby="1100" name="Institute of Medicine (IOM) National Healthcare Quality Report Categories">
    <field fieldid="50" ordby="1105" id="440" name="IOM Care Need" type="picklist-many">
      <fieldvalue value="Getting Better"/>
      <fieldvalue value="Living with Illness"/>
    </field>
    <field fieldid="51" ordby="1110" id="441" name="IOM Domain" type="picklist-many">
      <fieldvalue value="Effectiveness"/>
      <fieldvalue value="Patient-centeredness"/>
    </field>
  </section>
  <section secid="442" ordby="1200" name="Identifying Information and Availability">
    <field fieldid="97" ordby="1201" id="392" name="Bibliographic Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>Boulet LP, Turmel J, Irwin RS, CHEST Expert Cough Panel. Cough in the athlete: CHEST guideline and Expert Panel report. Chest. 2017 Feb;151(2):441-54. [76 references] <a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=27865877&quot; target=&quot;_blank&quot;>PubMed</a></td></tr></table>"/>
    </field>
    <field fieldid="124" ordby="1205" id="443" name="Adaptation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Not applicable; the guideline was not adapted from another source.</p></div>"/>
    </field>
    <field fieldid="128" ordby="1215" id="445" name="Date Released" type="text">
      <fieldvalue value="2017 Feb"/>
    </field>
    <field fieldid="158" ordby="1225" id="447" name="Guideline Developer(s)" type="orglist-p">
      <fieldvalue value="American College of Chest Physicians - Medical Specialty Society"/>
    </field>
    <field fieldid="125" ordby="1235" id="449" name="Source(s) of Funding" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The authors have reported to CHEST that no funding was received for this study.</p>
<p>The American College of Chest Physicians was the sole supporter of these guidelines, the <em>CHEST</em> journal article, and the innovations addressed within.</p></div>"/>
    </field>
    <field fieldid="126" ordby="1240" id="450" name="Guideline Committee" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>CHEST Expert Cough Panel</p></div>"/>
    </field>
    <field fieldid="127" ordby="1245" id="451" name="Composition of Group That Authored the Guideline" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><em>Panel Members</em>: Louis-Philippe Boulet, MD, FCCP; Julie Turmel, PhD; and Richard S. Irwin, MD, Master FCCP</p></div>"/>
    </field>
    <field fieldid="147" ordby="1250" id="452" name="Financial Disclosures/Conflicts of Interest" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Financial/Nonfinancial Disclosures</span></strong></p>
<p>L-P. B. has received nonprofit grants for research funding provided to the Institut universitaire de cardiologie et de pneumologie de Qu&amp;eacute;bec for participating in multicenter studies from Altair, Amgen, Asmacure, AstraZeneca, Boehringer Ingelheim, Boston Scientific, Genentech, GlaxoSmithKline, Novartis, Ono Pharma, Sanofi, and Wyeth and support for investigator-generated studies from Takeda, Merck, and Boehringer Ingelheim; has served on consulting/advisory boards for AstraZeneca and Novartis; has received nonprofit grants for production of educational materials from AstraZeneca, GlaxoSmithKline, Merck Frosst, Boehringer Ingelheim, and Novartis; has received lecture fees from AstraZeneca, GlaxoSmithKline, Merck, and Novartis; has received travel sponsorship to meetings for presentation of studies and for committees from Novartis and Takeda. Although R. S. I. is the Editor in Chief of <em>CHEST</em>, the review and all editorial decisions regarding this manuscript were made independently by others. None declared (J. T., R. S. I.)</p></div>"/>
    </field>
    <field fieldid="120" ordby="1256" id="393" name="Guideline Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the guideline.</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div>"/>
    </field>
    <field fieldid="118" ordby="1260" id="454" name="Guideline Availability" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Available from the <a href=&quot;http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/936027/101016jchest201610054.pdf&quot; title=&quot;CHEST Journal Web site&quot;>CHEST Journal Web site</a>. Also available to CHEST Journal subscribers through the <a href=&quot;http://journal.publications.chestnet.org/public/mobile.aspx&quot; title=&quot;CHEST Journal Web site&quot;>CHEST app</a> for iPhone, iPad, and iPod Touch.</p></div>"/>
    </field>
    <field fieldid="119" ordby="1265" id="455" name="Availability of Companion Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The following is available:</p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Lewis SZ, Diekemper RL, Ornelas J, Casey KR. Methodologies for the development of CHEST guidelines and Expert Panel reports. Chest. 2014 Jul;146(1):182-92. Available from the <a href=&quot;http://journal.chestnet.org/article/S0012-3692(15)48763-X/pdf&quot; title=&quot;CHEST Journal Web site&quot;>CHEST Journal Web site</a>. </li>
</ul></div>"/>
    </field>
    <field fieldid="143" ordby="1275" id="457" name="Patient Resources" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>None available</p></div>"/>
    </field>
    <field fieldid="142" ordby="1280" id="458" name="NGC Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This NGC summary was completed by ECRI Institute on May 4, 2017.</p>
<p>This NEATS assessment was completed by ECRI Institute on June 6, 2017. The guideline developer agreed to not review the content.</p></div>"/>
    </field>
    <field fieldid="141" ordby="1290" id="460" name="Copyright Statement" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div>"/>
    </field>
  </section>
  <section secid="99999" ordby="99999" name="Disclaimer">
    <field fieldid="99999" ordby="99999" id="99999" name="NGC Disclaimer" type="text">
      <fieldvalue value="<p>The National Guideline Clearinghouse (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;>NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p>"/>
    </field>
  </section>
</version><!--
     FILE ARCHIVED ON 22:55:51 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 14:07:33 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 45.648 (3)
  esindex: 0.01
  captures_list: 67.245
  CDXLines.iter: 13.747 (3)
  PetaboxLoader3.datanode: 45.582 (4)
  exclusion.robots: 0.336
  exclusion.robots.policy: 0.325
  RedisCDXSource: 4.036
  load_resource: 24.65
-->